1. Home
  2. TCI vs AQST Comparison

TCI vs AQST Comparison

Compare TCI & AQST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TCI
  • AQST
  • Stock Information
  • Founded
  • TCI 1983
  • AQST 2004
  • Country
  • TCI United States
  • AQST United States
  • Employees
  • TCI N/A
  • AQST N/A
  • Industry
  • TCI Real Estate
  • AQST Biotechnology: Pharmaceutical Preparations
  • Sector
  • TCI Finance
  • AQST Health Care
  • Exchange
  • TCI Nasdaq
  • AQST Nasdaq
  • Market Cap
  • TCI 239.1M
  • AQST 272.9M
  • IPO Year
  • TCI N/A
  • AQST 2018
  • Fundamental
  • Price
  • TCI $39.33
  • AQST $2.71
  • Analyst Decision
  • TCI
  • AQST Strong Buy
  • Analyst Count
  • TCI 0
  • AQST 5
  • Target Price
  • TCI N/A
  • AQST $11.40
  • AVG Volume (30 Days)
  • TCI 3.7K
  • AQST 1.7M
  • Earning Date
  • TCI 05-08-2025
  • AQST 05-12-2025
  • Dividend Yield
  • TCI N/A
  • AQST N/A
  • EPS Growth
  • TCI 59.61
  • AQST N/A
  • EPS
  • TCI 0.92
  • AQST N/A
  • Revenue
  • TCI $47,452,000.00
  • AQST $54,228,000.00
  • Revenue This Year
  • TCI N/A
  • AQST N/A
  • Revenue Next Year
  • TCI N/A
  • AQST $40.62
  • P/E Ratio
  • TCI $42.84
  • AQST N/A
  • Revenue Growth
  • TCI N/A
  • AQST 5.29
  • 52 Week Low
  • TCI $25.50
  • AQST $2.12
  • 52 Week High
  • TCI $40.15
  • AQST $5.80
  • Technical
  • Relative Strength Index (RSI)
  • TCI 73.06
  • AQST 54.01
  • Support Level
  • TCI $32.84
  • AQST $2.22
  • Resistance Level
  • TCI $40.15
  • AQST $2.79
  • Average True Range (ATR)
  • TCI 1.52
  • AQST 0.19
  • MACD
  • TCI 0.46
  • AQST 0.04
  • Stochastic Oscillator
  • TCI 88.78
  • AQST 75.64

About TCI Transcontinental Realty Investors Inc.

Transcontinental Realty Investors Inc is a fully integrated externally managed real estate company. It operates multifamily and commercial properties throughout the southern United States and also invests in mortgage notes receivable and in the land that is either held for appreciation or development. The company has two business segments: the acquisition, development, ownership, and management of multifamily properties which include the rental of apartments (Residential Segment) and other tenant services, including parking and storage space rental, and the acquisition, development, ownership, and management of commercial properties which are office properties(Commercial Segment). It includes the rental of office space and other tenant services, including parking and storage space rental.

About AQST Aquestive Therapeutics Inc.

Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.

Share on Social Networks: